The prognostic value of ventilatory efficiency with beta-blocker therapy in heart failure

Medicine and Science in Sports and Exercise

Volumn 39, Issue 2, 2007, Pages 213-219

  Arena, Ross A ^a   Guazzi, Marco ^b   Myers, Jonathan ^c   Abella, Joshua ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Exercise testing; Metabolic analysis; Mortality; Oxygen uptake

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL;

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CHI SQUARE TEST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART FAILURE; HUMAN; LINEAR REGRESSION ANALYSIS; LUNG CAPACITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PREDICTION; PRESCRIPTION; PROGNOSIS; SAMPLE SIZE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADRENERGIC BETA-ANTAGONISTS; EXERCISE TEST; EXHALATION; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33846849459     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/01.mss.0000241655.45500.c7     Document Type: Article

References (31)

1. AGOSTONI, P., M. GUAZZI, M. BUSSOTTI, S. DE VITA, and P. PALERMO. Carvedilol reduces the inappropriate increase of ventilation during exercise in heart failure patients. Chest 122:2062-2067, 2002.
2. ARENA, R., M. GUAZZI, J. MYERS, and M. A. PEBERDY. Prognostic characteristics of cardiopulmonary exercise testing in heart failure: comparing american and european models. Eur. J. Cardiovasc. Prev. Rehabil. 2:562-567, 2005.
3. ARENA, R., R. HUMPHREY, M. A. PEBERDY, and M. MADIGAN. Predicting peak oxygen consumption during a conservative ramping protocol: implications for the heart failure population. J. Cardiopulm. Rehabil. 23:183-189, 2003.
4. ARENA, R., J. MYERS, S. ASLAM, E. B. VARUGHESE, and M. A. PEBERDY. Technical considerations related to the minute ventialtion/carbon dioxide output slope in patients with heart failure. Chest 124:720-727, 2003.
5. 2 slope in patients with heart failure: a prognostic comparison. Am. Heart J. 147:354-360, 2004.
6. ARENA, R., J. MYERS, S. S. ASLAM, E. B. VARUGHESE, and M. A. PEBERDY. Impact of time past exercise testing on prognostic variables in heart failure. Int. J. Cardiol. 106:88-94, 2006.
7. BARD, R. L., B. W. GILLESPIE, N. S. CLARKE, T. G. EGAN, and J. M. NICKLAS. Determining the best ventilatory efficiency measure to predict mortality in patients with heart failure. J. Heart Lung Transplant. 25:589-595, 2006.
8. CHUA, T. P., P. PONIKOWSKI, D. HARRINGTON, et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J. Am. Coll. Cardiol. 29:1585-1590, 1997.
9. CORRA, U., A. MEZZANI, E. BOSIMINI, et al. Limited predictive value of cardiopulmonary exercise indices in patients with moderate chronic heart failure treated with carvedilol. Am. Heart J. 147:553-560, 2004.
10. DAVIES, L. C., D. P. FRANCIS, M. PIEPOLI, A. C. SCOTT, P. PONIKOWSKI, and A. J. COATS. Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification. Heart 83:147-151, 2000.
11. 2. Eur. Heart J. 21:154-161, 2000.
12. GIBBONS, R. J., G. J. BALADY, J. W. BEASLEY, et al. ACC/AHA guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J. Am. Coll. Cardiol. 30:260-311, 1997.
13. GUAZZI, M., J. MYERS, and R. ARENA. Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure. J. Am. Coll. Cardiol. 46 1883-1890, 2005.
14. GUAZZI, M., G. REINA, G. TUMMINELLO, and M. D. GUAZZI. Improvement of alveolar-capillary membrane diffusing capacity with exercise training in chronic heart failure. J. Appl. Physiol. 97:1866-1873, 2004.
15. HUNT, S. A., D. W. BAKER, M. H. CHIN, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Circulation 104:2996-3007, 2001.
16. KLEBER, F. X., G. VIETZKE, K. D. WERNECKE, et al. Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation 101:2803-2809, 2000.
17. LECHAT, P., M. PACKER, S. CHALON, M. CUCHERAT, T. ARAB, and J. P. BOISSEL. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 98:1184-1191, 1998.
18. MACGOWAN, G. A., and S. MURALI. Ventilatory and heart rate responses to exercise: better predictors of heart failure mortality than peak exercise oxygen consumption. Circulation 102:E182, 2000.
19. MANCINI, D. M., H. EISEN, W. KUSSMAUL, R. MULL, L. H. EDMUNDS Jr., and J. R. WILSON. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83:778-786, 1991.
20. METRA, M., C. L. DEI, G. PANINA, and O. VISIOLI. Exercise hyperventilation chronic congestive heart failure, and its relation to functional capacity and hemodynamics. Am. J. Cardiol. 70:622-628, 1992.
21. MYERS, J., L. GULLESTAD, R. VAGELOS, et al. Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited. Am. Heart J. 139:78-84, 2000.
22. O'NEILL, J. O., J. B. YOUNG, C. E. POTHIER, and M. S. LAUER. Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers. Circulation 111:2313-2318, 2005.
23. PETERSON, L. R., K. B. SCHECHTMAN, G. A. EWALD, et al. The effect of beta-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure. J. Heart Lung Transplant. 22:70-77, 2003.
24. PETERSON, L. R., K. B. SCHECHTMAN, G. A. EWALD, et al. Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers. J. Heart Lung Transplant. 22:1141-1148, 2003.
25. POHWANI, A. L., S. MURALI, M. M. MATHIER, et al. Impact of beta-blocker therapy on functional capacity criteria for heart transplant listing. J. Heart Lung Transplant. 22:78-86, 2003.
26. REINDL, I., K. D. WERNECKE, C. OPITZ, et al. Impaired ventilatory efficiency in chronic heart failure: possible role of pulmonary vasoconstriction. Am. Heart J. 136:778-785, 1998.
27. SHAKAR, S. F., B. D. LOWES, J. LINDENFELD, et al. Peak oxygen consumption and outcome in heart failure patients chronically treated with beta-blockers. J. Card. Fail. 10:15-20, 2004.
28. SMART, N., B. HALUSKA, R. LEANO, C. CASE, P. M. MOTTRAM, and T. H. MARWICK. Determinants of functional capacity in patients with chronic heart failure: role of filling pressure and systolic and diastolic function. Am. Heart J. 149:152-158, 2005.
29. SZLACHCIC, J., B. M. MASSIE, B. L. KRAMER, N. TOPIC, and J. TUBAU. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am. J. Cardiol. 55:1037-1042, 1985.
30. WITTE, K. K., S. THACKRAY, N. P. NIKITIN, J. G. CLELAND, and A. L. CLARK. The effects of long-term beta-blockade on the ventilatory responses to exercise in chronic heart failure. Eur. J. Heart Fail. 7:612-617, 2005.
31. ZUGCK, C., A. HAUNSTETTER, C. KRUGER, et al. Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J. Am. Coll. Cardiol. 39:1615-1622, 2002.